Here are six things to know:
1. Bioquark will test the theory on 20 clinically dead post-trauma patients.
2. The researchers may also infuse cocktail peptides to the spinal cord as well as perform nerve stimulation techniques.
3. Dr. Calixto Machada, a Cuban neurologist, will head the studies. He has authored many pieces on brain death.
4. The study will combine biologic regenerative medicine tools with central nervous system stimulation medical devices.
5. Bioquark hopes for results as early as two months into the study.
6. The trials will be held at Anupam Hospital in Rudrapur, Uttarakhand, India.
More articles on spine:
Improving spine surgical conversion rates with care coordination
UBMD Physicians Group names Dr. Kevin Gibbons executive director: 5 things to know
Mayo Clinic featured in article about post-spinal surgery complications — 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
